Kodiak Sciences logo

Kodiak Sciences

KOD | NASDAQ
Chart Builder DCF Calculator
$100.73
-$10.46 (-9.41%)
At close: Nov 16, 2026, 4:00 PM ET
$100.73
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:58 PM ET
-9.41%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
19.5
Fundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #997/1021 (Top 98%)

Key Statistics

Market Data

Market Cap $6.59B
1D Range
100.36 110.49
52W Range
19.22 111.19

Valuation (TTM)

PE -24.69
PB 523.97
EV/EBITDA -29.07

Valuation (NTM)

Forward PE N/A
Forward PEG 4.99
Price Target $116.00
Loading financial charts...

Profile

Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting th...

Sector Healthcare
Industry Biotechnology
Employees 141
IPO Date Oct 4, 2018
Website kodiak.com
Fiscal Year January - December

Latest News

Kodiak Sciences: Sticking With Hold As Optimistic Assumptions Are Already Priced In

3 days ago · seekingalpha.com

Kodiak Sciences: Sticking With Hold As Optimistic Assumptions Are Already Priced In
Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus

3 days ago · zacks.com

Kodiak Q3 Loss Wider Than Expected, Pipeline Development in Focus
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results

4 days ago · prnewswire.com

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
Kodiak Sciences to Present at Three Upcoming Investor Conferences

5 days ago · prnewswire.com

Kodiak Sciences to Present at Three Upcoming Investor Conferences
Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?

29 days ago · zacks.com

Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?
Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026

1 month ago · prnewswire.com

Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026
A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

2 months ago · 247wallst.com

A $32 Biotech Became a $90 Biotech Overnight. Is It Too Late to Buy Kodiak?

2 months ago · zacks.com

KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears

2 months ago · fool.com

Why Kodiak Sciences Skyrocketed Today
Kodiak Sciences Inc. (KOD) Discusses DAYBREAK Topline Data and Primary Endpoint Results Transcript

2 months ago · seekingalpha.com

Kodiak Sciences Inc. (KOD) Discusses DAYBREAK Topline Data and Primary Endpoint Results Transcript

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$116.00
Upside
+15.16%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.